GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer

Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum

(2017) David M. Gershenson et al.   JOURNAL OF CLINICAL ONCOLOGY

Development of Mouse Models to Study Ovarian Cancer Biology and Response Therapy.

(2017) Denise C. Connolly   BIOLOGY OF REPRODUCTION

A Systematic Review of Symptoms for the Diagnosis of Ovarian Cancer

(2016) Mark H. Ebell et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer

(2015) Seiji Mabuchi et al.   GYNECOLOGIC ONCOLOGY

Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies

(2015)   LANCET

Diagnosis of ovarian cancer

(2015) Sudha Sundar et al.   BMJ-British Medical Journal

Diagnosis of ovarian cancer

(2015) Sudha Sundar et al.   BMJ-British Medical Journal

TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells

(2014) Horacio Cardenas et al.   Epigenetics

17β-estradiol upregulates GREB1 and accelerates ovarian tumor progressionin vivo

(2014) Laura A. Laviolette et al.   INTERNATIONAL JOURNAL OF CANCER

Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer

(2014) Jennifer R. Ribeiro et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Estrogen stimulates the invasion of ovarian cancer cells via activation of the PI3K/AKT pathway and regulation of its downstream targets E-cadherin and α-actinin-4

(2014) ZHIYING LU et al.   Molecular Medicine Reports

A New Spontaneously Transformed Syngeneic Model of High-Grade Serous Ovarian Cancer with a Tumor-Initiating Cell Population

(2014) Curtis W. McCloskey et al.   Frontiers in Oncology

The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells

(2013) Yan Yan et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Tumor Repressor Protein 53 and Steroid Hormones Provide a New Paradigm for Ovarian Cancer Metastases

(2013) Lisa K. Mullany et al.   MOLECULAR ENDOCRINOLOGY

Precursors and pathogenesis of ovarian carcinoma

(2013) D. Lim et al.   PATHOLOGY

Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor

(2013) Hisham Mohammed et al.   Cell Reports

The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis

(2012) Chiara Pellegrini et al.   FERTILITY AND STERILITY

Inhibitory effects of the transcription factor Ets-1 on the expression of type I collagen in TGF-β1-stimulated renal epithelial cells

(2012) Kazuhiro Okano et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas

(2011) Vilde D Haakensen et al.   BMC CANCER

Type I collagen down-regulates E-cadherin expression by increasing PI3KCA in cancer cells

(2011) Jung-Chien Cheng et al.   CANCER LETTERS

Tissue-Specific Pathways for Estrogen Regulation of Ovarian Cancer Growth and Metastasis

(2010) M. A. Spillman et al.   CANCER RESEARCH

17β-Estradiol Accelerates Tumor Onset and Decreases Survival in a Transgenic Mouse Model of Ovarian Cancer

(2010) Laura A. Laviolette et al.   ENDOCRINOLOGY

Biological and biochemical consequences of global deletion of exon 3 from the ERα gene

(2010) Sylvia C. Hewitt et al.   FASEB JOURNAL

Issues and updates: evaluating estrogen receptor-α, progesterone receptor and HER2 in breast cancer

(2010) D Craig Allred   MODERN PATHOLOGY

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   Journal of Oncology Practice

Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody

(2009) H. J. Hnatyszyn et al.   BREAST CANCER RESEARCH AND TREATMENT

Estrous Cycle Modulates Ovarian Carcinoma Growth

(2009) G. N. Armaiz-Pena et al.   CLINICAL CANCER RESEARCH

Genomic actions of estrogen receptor α: what are the targets and how are they regulated?

(2009) Willem-Jan Welboren et al.   ENDOCRINE-RELATED CANCER

Connective tissue growth factor/CCN2-null mouse embryonic fibroblasts retain intact transforming growth factor-β responsiveness

(2007) Yasuji Mori et al.   EXPERIMENTAL CELL RESEARCH